Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli

Published:2009-01-15 Issue:3 Volume:63 Page:443-450
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Cambau E.,Matrat S.,Pan X.-S.,Roth Dit Bettoni R.,Corbel C.,Aubry A.,Lascols C.,Driot J.-Y.,Fisher L. M.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/63/3/443/2037272/dkn528.pdf

Reference49 articles.

1. Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones

2. Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity

3. Topoisomerase IV is a target of quinolones in Escherichia coli.

4. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones

5. Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds;European Journal of Medicinal Chemistry;2024-09

2. Interactions between Zoliflodacin and Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enzymological Basis for Cellular Targeting;ACS Infectious Diseases;2024-07-31

3. Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance;ACS Infectious Diseases;2024-04-02

4. Don't Be So Negative; Let's Have a Positive Perspective! A Review of Novel Antibiotics Targeting Gram-Positive Bacteria;Clinical Microbiology Newsletter;2022-12

5. STABILITY INDICATING RP-HPLC PDA ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BESIFLOXACIN HYDROCHLORIDE IN BULK AND FORMULATION;Indian Drugs;2022-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3